Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Gugu Maphalala

Biographic Data

ID7001618
NAMEGugu Maphalala
GIVEN NAMESGugu
FAMILY NAMEMaphalala
SIGNATUREMAPHALALA G
AFFILIATIONSMinistry of Health
ORCID0000-0002-3635-8405
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis

    Open Access•Tara E Ness, Mangaliso Ziyane et al.•ARTICLE•PLOS Global Public Health•2025

    In 2023, an estimated 10.8 million people developed tuberculosis, and 1.25 million people died from this disease, including 161,000 deaths in people with HIV (PWH) in whom tuberculosis remains the leading cause of death. Detecting Mycobacterium tuberculosis drug resistance remains a challenge among patients with paucibacillary tuberculosis; since there is such low bacterial load in their sputum it’s unable to be detected via microscopy, there is …

  • The impact of financial incentives on HIV incidence among adolescent girls and young women in Eswatini

    Open Access•Marelize Görgens, Sosthenes Ketende et al.•ARTICLE•BMJ Global Health•2022

    Introduction Incentives conditional on school attendance or on remaining free of sexually transmitted infections have produced mixed results in reducing HIV incidence. Methods HIV-negative adolescent girls and young women aged 15–22%–50% of whom were out of school—were recruited from 293 clusters in Eswatini from urban (30%) and rural areas (70%). Financial incentives conditional on education attendance were randomly allocated at the cluster leve…

  • Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin–piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini

    Open Access•Sibonakaliso Vilakati, Nontokozo Mngadi et al.•ARTICLE•BMJ Global Health•2021

    INTRODUCTION: To reduce malaria transmission in very low-endemic settings, screening and treatment near index cases (reactive case detection (RACD)), is widely practised, but the rapid diagnostic tests (RDTs) used miss low-density infections. Reactive focal mass drug administration (rfMDA) may be safe and more effective. METHODS: We conducted a pragmatic cluster randomised controlled trial in Eswatini, a very low-endemic setting. 77 clusters were…

  • Mother-to-Child Transmission of HIV and HIV-Free Survival in Swaziland

    Open Access•Caspian Chouraya, Rhoderick Machekano et al.•ARTICLE•AIDS and Behavior•2018

No prominent works on this page.

  • Mother-to-Child Transmission of HIV and HIV-Free Survival in Swaziland

    Open Access•Caspian Chouraya, Rhoderick Machekano et al.•ARTICLE•AIDS and Behavior•2018

  • Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin–piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini

    Open Access•Sibonakaliso Vilakati, Nontokozo Mngadi et al.•ARTICLE•BMJ Global Health•2021

    INTRODUCTION: To reduce malaria transmission in very low-endemic settings, screening and treatment near index cases (reactive case detection (RACD)), is widely practised, but the rapid diagnostic tests (RDTs) used miss low-density infections. Reactive focal mass drug administration (rfMDA) may be safe and more effective. METHODS: We conducted a pragmatic cluster randomised controlled trial in Eswatini, a very low-endemic setting. 77 clusters were…

  • The impact of financial incentives on HIV incidence among adolescent girls and young women in Eswatini

    Open Access•Marelize Görgens, Sosthenes Ketende et al.•ARTICLE•BMJ Global Health•2022

    Introduction Incentives conditional on school attendance or on remaining free of sexually transmitted infections have produced mixed results in reducing HIV incidence. Methods HIV-negative adolescent girls and young women aged 15–22%–50% of whom were out of school—were recruited from 293 clusters in Eswatini from urban (30%) and rural areas (70%). Financial incentives conditional on education attendance were randomly allocated at the cluster leve…

  • Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis

    Open Access•Tara E Ness, Mangaliso Ziyane et al.•ARTICLE•PLOS Global Public Health•2025

    In 2023, an estimated 10.8 million people developed tuberculosis, and 1.25 million people died from this disease, including 161,000 deaths in people with HIV (PWH) in whom tuberculosis remains the leading cause of death. Detecting Mycobacterium tuberculosis drug resistance remains a challenge among patients with paucibacillary tuberculosis; since there is such low bacterial load in their sputum it’s unable to be detected via microscopy, there is …

Medicine (3 works) · Adolescent Sexual and Reproductive Health (2 works) · Demography (2 works) · Environmental health (2 works) · HIV/AIDS Research and Interventions (2 works) · Immunology (2 works) · Pediatrics (2 works) · Adverse effect (1 work) · Artemether/lumefantrine (1 work) · Artemisinin (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae